Fishman DA - Search Results

1

Soluble epidermal growth factor receptor: a biomarker of epithelial ovarian cancer.

Baron AT, Lafky JM, Boardman CH, Cora EM, Buenafe MC, Liu D, Rademaker A, Fishman DA, Podratz KC, Reiter JL, Maihle NJ. Baron AT, et al. Among authors: fishman da. Cancer Treat Res. 2009;149:189-202. doi: 10.1007/978-0-387-98094-2_9. Cancer Treat Res. 2009. PMID: 19763437 Review. No abstract available.

2

Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.

Baron AT, Boardman CH, Lafky JM, Rademaker A, Liu D, Fishman DA, Podratz KC, Maihle NJ. Baron AT, et al. Among authors: fishman da. Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):306-18. doi: 10.1158/1055-9965.EPI-04-0423. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15734951

3

Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.

Baron AT, Cora EM, Lafky JM, Boardman CH, Buenafe MC, Rademaker A, Liu D, Fishman DA, Podratz KC, Maihle NJ. Baron AT, et al. Among authors: fishman da. Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):103-13. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12582019

4

The scientific basis of early detection of epithelial ovarian cancer: the National Ovarian Cancer Early Detection Program (NOCEDP).

Fishman DA, Bozorgi K. Fishman DA, et al. Cancer Treat Res. 2002;107:3-28. doi: 10.1007/978-1-4757-3587-1_1. Cancer Treat Res. 2002. PMID: 11775458 Review. No abstract available.

5

Localization of the activin signal transduction components in normal human ovarian follicles: implications for autocrine and paracrine signaling in the ovary.

Pangas SA, Rademaker AW, Fishman DA, Woodruff TK. Pangas SA, et al. Among authors: fishman da. J Clin Endocrinol Metab. 2002 Jun;87(6):2644-57. doi: 10.1210/jcem.87.6.8519. J Clin Endocrinol Metab. 2002. PMID: 12050229

6

Ultrasound and ovarian cancer.

Cohen L, Fishman DA. Cohen L, et al. Among authors: fishman da. Cancer Treat Res. 2002;107:119-32. doi: 10.1007/978-1-4757-3587-1_5. Cancer Treat Res. 2002. PMID: 11775447 Review.

7

Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells.

Cowden Dahl KD, Symowicz J, Ning Y, Gutierrez E, Fishman DA, Adley BP, Stack MS, Hudson LG. Cowden Dahl KD, et al. Among authors: fishman da. Cancer Res. 2008 Jun 15;68(12):4606-13. doi: 10.1158/0008-5472.CAN-07-5046. Cancer Res. 2008. PMID: 18559505 Free PMC article.

8

Whole-abdominal radiation in endometrial carcinoma: an analysis of toxicity, patterns of recurrence, and survival.

Small W Jr, Mahadevan A, Roland P, Vallow L, Zusag T, Fishman D, Massad S, Rademaker A, Kalapurakal JA, Chang S, Lurain J. Small W Jr, et al. Cancer J. 2000 Nov-Dec;6(6):394-400. Cancer J. 2000. PMID: 11131490

9

Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells.

Symowicz J, Adley BP, Gleason KJ, Johnson JJ, Ghosh S, Fishman DA, Hudson LG, Stack MS. Symowicz J, et al. Among authors: fishman da. Cancer Res. 2007 Mar 1;67(5):2030-9. doi: 10.1158/0008-5472.CAN-06-2808. Cancer Res. 2007. PMID: 17332331

10

Proinvasive properties of ovarian cancer ascites-derived membrane vesicles.

Graves LE, Ariztia EV, Navari JR, Matzel HJ, Stack MS, Fishman DA. Graves LE, et al. Among authors: fishman da. Cancer Res. 2004 Oct 1;64(19):7045-9. doi: 10.1158/0008-5472.CAN-04-1800. Cancer Res. 2004. PMID: 15466198

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

155 results

Search Page